Peng Liu1, Peng Li, Wen He, Li-Qin Zhao. 1. Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Abstract
AIM: To study the liver and spleen volume variations in hepatic fibrosis patients at different histopathological stages. METHODS: Multidetector computed tomography (MDCT) scan was performed in 85 hepatic fibrosis patients. Liver volume (LV) and spleen volume (SV) were measured. Fifteen healthy individuals served as a control group (S0). The patients were divided into stage 1 (S1) group (n = 34), stage 2 (S2) group (n = 25), stage 3 (S3) group (n = 16), and stage 4 (S4) group (n = 10) according to their histopathological stage of liver fibrosis. RESULTS: The LV and standard LV(SLV)had a tendency to increase with the severity of fibrosis, but no statistical difference was observed in the 5 groups (LV: F = 0.245, P = 0.912; SLV: F = 1.902, P = 0.116). The SV was gradually increased with the severity of fibrosis, and a statistically significant difference in SV was observed among the 5 groups (P < 0.01). The LV/SV ratio and SLV/SV ratio were gradually decreased with the aggravation of hepatic fibrosis, and statistically significant differences in both LV/SV and SLV/SV were found among the 5 groups (P < 0.01). CONCLUSION: The absence of obvious LV reduction in patients with chronic liver disease may be a morphological index of patients without liver cirrhosis. The SV is related to the severity of fibrosis, and the spleen of patients with advanced fibrosis is enlarged evidently. The LV/SV ratio and SLV/SV ratio are of a significant clinical value in the diagnosis of advanced liver fibrosis.
AIM: To study the liver and spleen volume variations in hepatic fibrosispatients at different histopathological stages. METHODS: Multidetector computed tomography (MDCT) scan was performed in 85 hepatic fibrosispatients. Liver volume (LV) and spleen volume (SV) were measured. Fifteen healthy individuals served as a control group (S0). The patients were divided into stage 1 (S1) group (n = 34), stage 2 (S2) group (n = 25), stage 3 (S3) group (n = 16), and stage 4 (S4) group (n = 10) according to their histopathological stage of liver fibrosis. RESULTS: The LV and standard LV(SLV)had a tendency to increase with the severity of fibrosis, but no statistical difference was observed in the 5 groups (LV: F = 0.245, P = 0.912; SLV: F = 1.902, P = 0.116). The SV was gradually increased with the severity of fibrosis, and a statistically significant difference in SV was observed among the 5 groups (P < 0.01). The LV/SV ratio and SLV/SV ratio were gradually decreased with the aggravation of hepatic fibrosis, and statistically significant differences in both LV/SV and SLV/SV were found among the 5 groups (P < 0.01). CONCLUSION: The absence of obvious LV reduction in patients with chronic liver disease may be a morphological index of patients without liver cirrhosis. The SV is related to the severity of fibrosis, and the spleen of patients with advanced fibrosis is enlarged evidently. The LV/SV ratio and SLV/SV ratio are of a significant clinical value in the diagnosis of advanced liver fibrosis.
Authors: S Nawaratne; R Fabiny; J E Brien; J Zalcberg; W Cosolo; A Whan; D J Morgan Journal: J Comput Assist Tomogr Date: 1997 May-Jun Impact factor: 1.826
Authors: K Tarao; H Hoshino; I Motohashi; K Iimori; S Tamai; Y Ito; S Takagi; Y Oikawa; S Unayama; T Fujiwara Journal: Hepatology Date: 1989-04 Impact factor: 17.425
Authors: Hannu T Huhdanpaa; Peng Zhang; Venkataramu N Krishnamurthy; Chris Douville; Binu Enchakolody; Chris Chou; Sampathkumar Ethiraj; Stewart Wang; Grace L Su Journal: J Digit Imaging Date: 2014-10 Impact factor: 4.056
Authors: Sylviane Hanquinet; Delphine S Courvoisier; Anne-Laure Rougemont; Amira Dhouib; Laura Rubbia-Brandt; Barbara E Wildhaber; Laura Merlini; Valerie A McLin; Mehrak Anooshiravani Journal: Pediatr Radiol Date: 2015-05-06
Authors: Devika Kapuria; Gil Ben-Yakov; Rebecca Ortolano; Min Ho Cho; Or Kalchiem-Dekel; Varun Takyar; Shilpa Lingala; Naveen Gara; Michele Tana; Yun Ju Kim; David E Kleiner; Neal S Young; Danielle M Townsley; Christopher Koh; Theo Heller Journal: Hepatology Date: 2019-04-10 Impact factor: 17.425